In 2023, the United States recorded the highest mortality rate for musculoskeletal and connective tissue diseases, at 6.66 thousand male deaths, followed by Japan with 3.88. Growth trends since 2018 show variations, with the United States (+4.61%), Germany (+7.48%), and Argentina (+5.78%) at notable growth rates. Declining trends were noted in Colombia (-5.78%) and Latvia (-5.06%).
Future trends to watch include the potential for increased mortality rates due to aging populations and lifestyle factors in developed countries, while advancements in healthcare technology might help reduce these rates in others. Monitoring lifestyle changes and healthcare access will be crucial to understanding future shifts.
Top countries in Musculoskeletal System and Connective Tissue Diseases Mortality by Country
| # | 10 Countries | Units (Male Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 6,660 | 2023 | +2.39% | +4.61% | View data |
| 2 | 2 Japan | 3,880 | 2023 | +3.13% | +2.51% | View data |
| 3 | 3 Germany | 2,740 | 2023 | +6.49% | +7.48% | View data |
| 4 | 4 Brazil | 2,700 | 2023 | +2.98% | +3.13% | View data |
| 5 | 5 Mexico | 1,810 | 2023 | +0.61% | +3.2% | View data |
| 6 | 6 Spain | 1,720 | 2023 | +2.07% | +0.72% | View data |
| 7 | 7 United Kingdom | 1,590 | 2023 | +0.32% | +0.46% | View data |
| 8 | 8 Canada | 836 | 2023 | +2.45% | +2.83% | View data |
| 9 | 9 South Africa | 753 | 2023 | +0.94% | +0.46% | View data |
| 10 | 10 Australia | 606 | 2023 | +3.06% | +3.67% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
